Market cap
₹25,697 Cr
Revenue (TTM)
₹2,192 Cr
P/E Ratio
73.6
P/B Ratio
10.3
Div. Yield
0 %
Quality Score
7/10
Growth Score
8/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹349 Cr
-
ROE
11 %
-
ROCE
15.5 %
-
Industry P/E
--
-
EV/EBITDA
37.8
-
Debt to Equity
0
-
Book Value
₹117.1
-
EPS
₹16.9
-
Face value
1
-
Shares outstanding
212,115,515
10 Years Aggregate
CFO
₹1,112.96 Cr
EBITDA
₹1,755.59 Cr
Net Profit
₹604.69 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sai Life Sciences
| 34.3 | 9.4 | 17.6 | 65.5 | -- | -- | -- |
|
BSE Healthcare
| 8.6 | 1.3 | 8.3 | 9.1 | 24.9 | 13.5 | 12.1 |
|
Company
|
2025
|
|---|---|
|
Sai Life Sciences
| 19.8 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sai Life Sciences
|
1,220.0 | 25,696.7 | 2,192.5 | 348.9 | 21.2 | 14.9 | 73.6 | 10.3 |
| 184.6 | 2,878.5 | 2,931.9 | 97.5 | 7.7 | 1.5 | 29.5 | 0.4 | |
| 144.7 | 641.7 | 410.8 | 38.0 | 7.2 | 11.9 | 16.7 | 1.5 | |
| 522.4 | 12,622.0 | 3,510.5 | 401.1 | 14.0 | 13.9 | 31.5 | 4.0 | |
| 70.1 | 247.8 | 128.4 | -10.4 | -9.4 | -10.4 | -- | 2.7 | |
| 250.8 | 11,315.5 | 2,950.9 | 420.1 | 17.0 | 14.6 | 27.1 | 3.7 | |
| 21.7 | 649.8 | 1,449.5 | 55.0 | 6.8 | 11 | 12.5 | 1.3 | |
| 4,720.0 | 10,944.6 | 935.0 | 257.9 | 34.3 | 78.9 | 42.4 | 24.2 | |
| 29.5 | 436.4 | 54.2 | 10.9 | -4.1 | 13.9 | 40.2 | 14.1 | |
| 24.5 | 54.3 | 53.3 | -1.7 | 20.3 | -14.9 | -- | 0.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsSai Life Sciences IPO analysis
5 min read•By Abhinav Goel
About Sai Life Sciences
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The... company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India. Read more
-
Incorporated
1999
-
Chairman
Kanumuri Ranga Raju
-
Managing Director
Krishnam Raju Kanumuri
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Sai Life Sciences Ltd’s IPO? Explore our IPO Details page.
Quarterly Updates
FAQs for Sai Life Sciences
What is the current share price of Sai Life Sciences Ltd Today?
The share price of Sai Life Sciences Ltd is ₹1,220.00 (NSE) and ₹1,218.60 (BSE) as of 09-Jun-2026 14:34 IST. Sai Life Sciences Ltd has given a return of 65.49% in the last 1 years.
What is the current PB & PE ratio of Sai Life Sciences Ltd?
The P/E ratio of Sai Life Sciences Ltd is 73.65 times as on 09-Jun-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
93.36
|
7.48
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Sai Life Sciences Ltd?
The 52-week high and low of Sai Life Sciences Ltd are Rs 1,222.00 and Rs 716.60 as of 09-Jun-2026.
What is the market cap of Sai Life Sciences Ltd?
Sai Life Sciences Ltd has a market capitalisation of ₹ 25,697 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Sai Life Sciences Ltd?
Before investing in Sai Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
